Effects of induced hyperprolactinemia on in vitro fertilization cycles

• Published in: Fertility and sterility Vol. 63; no. 2; pp. 371 - 376
• Main Authors: Piekos, Marek W., Binor, Zvi, Rawlins, Richard G., Radwanska, Ewa
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.02.1995; Elsevier Science
• Subjects: Biological and medical sciences; Birth control; Chorionic Gonadotropin - therapeutic use; Estradiol - blood; Estradiol - metabolism; Female; fertilization; Fertilization in Vitro; Follicular Fluid - metabolism; Gynecology. Andrology. Obstetrics; Humans; Hyperprolactinemia; Hyperprolactinemia - blood; Hyperprolactinemia - chemically induced; IVF; Leuprolide - therapeutic use; Medical sciences; Menotropins - adverse effects; Menotropins - therapeutic use; Ovulation Induction; Pregnancy; Progesterone - blood; Progesterone - metabolism; Sterility. Assisted procreation; IVF; fertilization; Hyperprolactinemia; ovulation induction; pregnancy; Human; Agonist; HMG; Induction; Peptide hormone; Assisted procreation; Gonadotropin RH; Gonadotropin; Luteinization; Glycoprotein hormone; Fecundation; HCG; In vitro; Ovulation; Placental hormone; Hypothalamic hormone; Endogenous; Complication; Female; Biological effect; Hormone releasing factor

To investigate the effect of induced endogenous hyperprolactinemia on the luteinization process, as expressed by the shift in the P:E2 ratio after hCG injection in IVF cycles. Serum PRL, E2, and P levels were measured in 49 IVF patients (leuprolide acetate and hMG protocol) on the day of hCG injecti...